Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Reversing cellular age isn’t science fiction, but the biology is more complicated than either the skeptics or the hype ...
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that enables safe modification of multiple genes in primary ...
The South San Francisco biotech plans to begin its first human trial of a liver cell-reprogramming therapy next year ...
As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...
NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...
In the cancer type multiple myeloma, the malignant cells differ significantly from normal cells regarding the layer of chemical "tags" on DNA and proteins that control whether genes are turned on or ...
Researchers developed an OSK therapy that can partially reset epigenetic aging in optic neurons. Preclinical data ...
The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
Lactate, once considered a metabolic waste product, is now recognized as a key regulator of cellular homeostasis and disease progression. In gynecological malignancies-including ovarian, cervical, and ...
The Hearty Soul on MSN
The world's first reverse aging drug was just injected into a human
The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results